Abecma (Idecabtagene vicleucel)

Overview
Abecma is a therapy approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory multiple myeloma after four or more prior therapies, including an immunomodulatory agent,… read more

Adriamycin (Doxorubicin)

The Adriamycin brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to… read more

Alkeran (Melphalan)

The Alkeran brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to your…

Aredia (Pamidronate)

Overview
Aredia is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat and prevent osteolytic (bone) lesions caused by multiple myeloma. Some doctors may also prescribe Aredia for people… read more

Autologous (self) stem cell transplant

Overview
Stem cell transplant after high-dose chemotherapy is the most common treatment for people when first diagnosed with multiple myeloma. The purpose of a stem cell transplant in multiple myeloma is to replace… read more

BiCNU (Carmustine)

Overview
BiCNU is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating multiple myeloma and other cancers. BiCNU is often combined with other drugs such as corticosteroids.… read more

Blenrep (Belantamab Mafodotin-Blmf) for Multiple Myeloma

Overview
Blenrep is approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory multiple myeloma who have received at least two prior treatments, including a proteasome inhibitor…

Boruzu (Bortezomib)

Overview
Boruzu is approved by the U.S. Food and Drug Administration (FDA) for treating adults with multiple myeloma. It may be used as an initial treatment or as part of retreatment if the disease returns. Eligibility…

Carvykti (Ciltacabtagene autoleucel)

Overview
Carvykti is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed or refractory multiple myeloma in adults who have already tried at least four lines of therapy.… read more

Cytoxan (Cyclophosphamide)

The Cytoxan brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to your… read more

Darzalex (Daratumumab)

Overview
Darzalex is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating multiple myeloma in people who have tried other therapies or who are ineligible for autologous stem… read more

Darzalex Faspro (Daratumumab and Hyaluronidase-Fihj)

Overview
Darzalex Faspro is approved by the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma in adults. This treatment is used in combination with other drugs such as bortezomib, lenalidomide…

Doxil (Doxorubicin liposomal)

Overview

Doxil is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating cancers including multiple myeloma. In cases of myeloma, Doxil is usually combined with Velcade and…

Elrexfio (Elranatamab-Bcmm)

Overview
Elrexfio is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory multiple myeloma who’ve received at least four prior lines of therapy,… read more

Empliciti (Elotuzumab)

Overview
Empliciti is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat multiple myeloma in people who have tried other therapies. Empliciti is often combined with Pomalyst or Re… read more

Evomela (Melphalan)

Overview
Evomela is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating multiple myeloma. Evomela is often combined with other drugs such as Velcade or Thalomid and a corticost… read more

Farydak (Panobinostat)

The Farydak brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to your… read more

Kyprolis (Carfilzomib)

Overview
Kyprolis is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat multiple myeloma in people who have tried other therapies. Kyprolis is often combined with a corticosteroid… read more

Lynozyfic (Linvoseltamab-Gcpt)

Overview
Lynozyfic is approved by the U.S. Food and Drug Administration (FDA) under accelerated approval for adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy…

Mozobil (Plerixafor)

Overview
Mozobil is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat multiple myeloma and non-Hodgkin lymphoma. Mozobil is also known by its drug name, plerixafor.

Mozobil is a… read more

Neulasta (Pegfilgrastim)

Overview
Neulasta is a prescription drug approved by the Food and Drug Administration (FDA) to lower the risk of developing infections after receiving chemotherapy or some types of radiation. Neulasta is also known by… read more

Ninlaro (Ixazomib)

Overview
Ninlaro is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat multiple myeloma in people who have tried at least one other therapy. Ninlaro is often combined with a corti… read more

Norpramin (Desipramine)

Overview
Norpramin is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for the treatment of depression. Norpramin may be mildly effective at managing neuropathic pain, a common side… read more

Oncovin (Vincristine)

Overview
Oncovin is a prescription medication used to treat several types of cancer. Oncovin is sometimes combined with other drugs such as Adriamycin (doxorubicin) and a corticosteroid in a chemotherapy regimen to… read more

Osenvelt (Denosumab-Bmwo)

Overview
Osenvelt is approved by the U.S. Food and Drug Administration (FDA) to prevent skeletal-related events in people with multiple myeloma and in those with bone metastases from solid tumors. Skeletal-related events…

Pomalyst (Pomalidomide)

Overview
Pomalyst is a prescription medication approved by the Food and Drug Administration (FDA) to treat multiple myeloma that has progressed after being treated with other therapies. Pomalyst is often combined with a… read more

Radiation therapy

Overview
Radiation therapy (also called radiotherapy) is commonly used to treat solitary plasmacytoma – an early stage of multiple myeloma involving a single lesion in the bone or soft tissues. Plasmacytoma that occurs… read more

Revlimid (Lenalidomide)

Overview
Revlimid is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat multiple myeloma. Revlimid is often combined with a corticosteroid like dexamethasone to treat newly… read more

Sarclisa (Isatuximab-Irfc)

Overview
Sarclisa is approved by the U.S. Food and Drug Administration (FDA) for use in adults with multiple myeloma. It is indicated for individuals who have previously received at least two therapies, including…

Talvey (Talquetamab-Tgvs)

Overview
Talvey is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed or refractory multiple myeloma in adults who have already tried at least four lines of therapy. These…

Tecvayli (Teclistamab-Cqyv) for Myeloma

Overview
Tecvayli is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with relapsed or refractory multiple myeloma. It may be used in combination with daratumumab hyaluronidase-fihj in…

Velcade (Bortezomib)

Overview
Velcade is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating multiple myeloma. Velcade is often combined with a corticosteroid and other drugs such as Cytoxan, Revli… read more

Xbryk (Denosumab-Dssb)

Overview
Xbryk (denosumab-dssb) is approved by the U.S. Food and Drug Administration (FDA) to help prevent skeletal-related events in people with multiple myeloma or bone metastases from solid tumors. These events can…

Xgeva (Denosumab)

Overview
Xgeva is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to prevent fractures and spinal cord compression in people whose bones have been weakened by multiple myeloma. Xgeva is… read more

Xpovio (selinexor)

Overview
Xpovio is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed or refractory multiple myeloma in adults who have received at least four prior therapies. Xpovio is also… read more

Zometa (Zoledronic acid)

The Zometa brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to your… read more